The introduction of GLP-1 weight-loss drugs has transformed the landscape of obesity treatment, presenting an opportunity for millions seeking effective solutions. Drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound are at the forefront of this revolution, promising significant health benefits and garnering billions in revenue for their manufacturers. However, as promising as they are, […]